Issued Patents All Time
Showing 26–37 of 37 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 8865666 | Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof | Said M. Sebti | 2014-10-21 |
| 8828451 | Akt sensitization of cancer cells | Said M. Sebti | 2014-09-09 |
| 8822524 | Substrate-mimetic Akt inhibitor | Said M. Sebti, Andrew D. Hamilton, Katherine J. Kayser-Bricker | 2014-09-02 |
| 8691779 | Compositions including triciribine and taxanes and methods of use thereof | Said M. Sebti | 2014-04-08 |
| 8673868 | Compositions including triciribine and one or more platinum compounds and methods of use thereof | Said M. Sebti | 2014-03-18 |
| 8673867 | Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof | Said M. Sebti | 2014-03-18 |
| 8623834 | Compositions including triciribine and trastuzumab and methods of use thereof | Said M. Sebti | 2014-01-07 |
| 8476241 | Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds | — | 2013-07-02 |
| 8435550 | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device | Stephen Dugan, Gordon Stewart, Gina Zhang, Nancy Kirsten, Paul Consigny +4 more | 2013-05-07 |
| 8435959 | Effective treatment of tumors and cancer with triciribine and related compounds | Said M. Sebti | 2013-05-07 |
| 8183249 | Inhibitors of AKT/PKB with anti-tumor activity | Mei Sun, Said M. Sebti | 2012-05-22 |
| 8178502 | Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds | — | 2012-05-15 |